Delivery Order HHSN261201600012I-HHSN26100001

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Biopartners, Inc. for the TSS CPTAC DIGITAL MEDICAL IMAGES OF CPTAC BIOSPECIMENS project. The contract has a ceiling value of $12,240.00 and an ultimate completion date of September 17, 2018. It is part of the Tissue Source Site for Tumor Analysis master IDIQ contract. The contract does not have a set-aside designation. The award supports the NCI's Medical Images for CPTAC Biospecimens program.

This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Biomatrix LLC, a woman-owned and Asian-Pacific American-owned limited liability company, for $348,699.80. The award is for Biomatrix to serve as a Tissue Source Site (TSS) for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract has a period of performance through April 29, 2019 and does not have a set-aside designation. The CPTAC program is focused on the...

This is a federal contract award to Leidos Biomedical Research Inc. by the National Cancer Institute (NCI), a civilian agency, for the Delivery Order "DCTD TUMOR TISSUE ACQUISITION". The contract has a ceiling value of $2,624,297.00 and was awarded on September 19, 2016, with an ultimate completion date of September 18, 2021. The contract is a Delivery Order and uses a Cost No Fee pricing type. There is no set-aside designation for this award. Leidos Biomedical Research Inc. is a...

This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...

This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...

This is a Firm Fixed Price Delivery Order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Indivumed, Inc., a For Profit Organization. The contract is for the recovery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The potential value of this contract is $38,000.00. It is not associated with a set-aside designation. The contract is issued under the NCI Cancer Genome...

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

This is a $98,100.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Asterand US Acquisition Corporation, a for-profit organization. The contract is under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract vehicle and is set aside for small businesses. The purpose of the contract is to provide tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. The ultimate completion date for the contract is August...

<p>This is a Firm Fixed Price Delivery Order awarded by the National Cancer Institute (NCI), a civilian agency, to Mary Bruce Ganges Biological Research Consultant, a woman-owned small business. The contract is for a Tissue Culture Technician to support the NCI Surgery Branch, with a ceiling value of $79,400.00. The contract does not have a set-aside designation and was awarded on May 30, 2008, with a final completion date of April 30, 2010.</p>